A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia
Recruiting
Phase 4
Interventional Study
Functional Dyspepsia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 19 – 75
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Main Inclusion Criteria:
* Men or women aged 19 to 75 years, inclusive
* Subjects diagnosed with functional dyspepsia according to the Rome IV criteria
* Subjects with at least three symptoms rated as moderate or severe on the Gastrointestinal Symptom Score(GIS)
* Subjects who voluntarily signed a …
Contacts